Introduction
Units & Dose
Converters
Math Calculator
Medical Equations
Clinical Criteria
Decision Trees
Search by Specialty
EMR Edition
Pocket PC Edition
Mobile Edition
Purchase Subscription
| Endocarditis Diagnostic Criteria -- Duke Criteria |
The MedCalc 3000 module Endocarditis Diagnostic Criteria -- Duke Criteria is available in MedCalc 3000 Complete Edition.
This calculator evaluates the following Clinical Criteria:
- Positive blood culture for typical Infective Endocarditis organisms (strep viridins or bovis, HACEK, staph aureous without other primary site, enterococcus), from 2 separate blood cultures or 2 positive cultures from samples drawn > 12 hours apart, or 3 or a majority of 4 separate cultures of blood (first and last sample drawn 1 hour apart)
- Echocardiogram with oscillating intracardiac mass on valve or supporting structures, in the path of regurgitant jets, or on implanted material in the absence of an alternative anatomic explanation, or abscess, or new partial dehiscence of prosthetic valveb or new valvular regurgitation
- Predisposing heart condition or intravenous drug use
- Temp > 38.0° C (100.4° F)
- Vascular phenomena: arterial emboli, pulmonary infarcts, mycotic aneurysms, intracranial bleed, conjunctival hemorrhages, Janeway lesions
- Immunologic phenomena: glomerulonephritis, Osler nodes, Roth spots, rheumatoid factor
- Microbiological evidence: positive blood culture but does not meet a major criterion as noted above or serological evidence of active infection with organism consistent with endocarditis (excluding coag neg staph, and other common contaminants)
- Echocardiographic findings: consistent with endocarditis but do not meet a major criterion as noted above
| All information contained in and produced by the MedCalc 3000 system is provided for educational purposes only. This information should not be used for the diagnosis or treatment of any health problem or disease. THIS INFORMATION IS NOT INTENDED TO REPLACE CLINICAL JUDGMENT OR GUIDE INDIVIDUAL PATIENT CARE IN ANY MANNER. Click here for full notice and disclaimer. |